Tower Research Capital LLC (Trc) Iterum Therapeutics PLC Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.31 - $0.45 $8,420 - $12,222	-27,162 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.39 - $0.74 $10,593 - $20,099	27,162 New	27,162 $11,000
Q3 2021 Nov 15, 2021	SELL	$0.54 - $2.29 $62,846 - $266,514	-116,382 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.97 - $2.39 $112,803 - $277,937	116,292 Added 129213.33%	116,382 $269,000
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $87 - $245	90 New	90 $0
Q4 2019 Feb 07, 2020	SELL	$1.7 - $5.99 $1 - $5	-1 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$5.77 - $7.65 $5,631 - $7,466	-976 Reduced 99.9%	1 $0
Q2 2019 Aug 13, 2019	BUY	$6.09 - $9.1 $633 - $946	104 Added 11.91%	977 $7,000
Q1 2019 May 14, 2019	BUY	$4.88 - $8.17 $751 - $1,258	154 Added 21.42%	873 $7,000
Q4 2018 Feb 14, 2019	SELL	$5.01 - $7.9 $12,114 - $19,102	-2,418 Reduced 77.08%	719 $4,000
Q3 2018 Nov 13, 2018	BUY	$6.24 - $10.4 $19,106 - $31,844	3,062 Added 4082.67%	3,137 $21,000
Q2 2018 Aug 15, 2018	BUY	$10.67 - $12.85 $800 - $963	75 New	75 $1,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $19M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.